Aerwave Medical Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$12M
- Investors
-
2
Aerwave Medical General Information
Description
Developer of interventional therapies intended to treat pulmonary diseases. The company offers alternative treatments to traditional medications for conditions such as asthma, COPD and other advanced lung diseases, enabling healthcare institutions to address a significant unmet medical need.
Contact Information
Website
www.aerwavemed.comCorporate Office
- 12345 Main Street
- Briarwood
- New York, NY
- United States
Corporate Office
- 12345 Main Street
- Briarwood
- New York, NY
- United States
Aerwave Medical Timeline
Aerwave Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 08-Jan-2025 | $12M | Completed | Generating Revenue | ||
| 3. Accelerator/Incubator | 01-Nov-2024 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 17-Aug-2023 | $3.97M | $7.97M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 24-Feb-2021 | $4M | $4M | Completed | Generating Revenue |
Aerwave Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Aerwave Medical Patents
Aerwave Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026101700-A1 | Virtual ablation tool for interstitial trans-bronchial catheter therapy of lung tumors with circumferential ultrasound ablation | Pending | 11-Nov-2024 | ||
| EP-4601549-A2 | Method and apparatus for treatment of pulmonary conditions | Pending | 14-Oct-2022 | ||
| EP-4601549-A4 | Method and apparatus for treatment of pulmonary conditions | Pending | 14-Oct-2022 | ||
| EP-4601741-A1 | Method and apparatus for treatment of pulmonary conditions | Pending | 14-Oct-2022 | ||
| US-20260123952-A1 | Method and apparatus for treatment of pulmonary conditions | Pending | 14-Oct-2022 | A61B17/320068 |
Aerwave Medical Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Long Island High Technology Incubator | Accelerator/Incubator | |||
| Lucius Partners | Corporation | Minority |
Aerwave Medical FAQs
-
When was Aerwave Medical founded?
Aerwave Medical was founded in 2020.
-
Where is Aerwave Medical headquartered?
Aerwave Medical is headquartered in New York, NY.
-
What industry is Aerwave Medical in?
Aerwave Medical’s primary industry is Drug Discovery.
-
Is Aerwave Medical a private or public company?
Aerwave Medical is a Private company.
-
What is Aerwave Medical’s current revenue?
The current revenue for Aerwave Medical is .
-
How much funding has Aerwave Medical raised over time?
Aerwave Medical has raised $20M.
-
Who are Aerwave Medical’s investors?
Long Island High Technology Incubator and Lucius Partners have invested in Aerwave Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process